Indian Immunologicals
NSE:IIMMHyderabad, India· Est.
India's top veterinary and human vaccine maker with a global export footprint.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileAI Company Overview
India's top veterinary and human vaccine maker with a global export footprint.
VeterinaryHuman Vaccines
Technology Platform
Vero cell culture and recombinant protein platforms for large‑scale vaccine production, complemented by advanced purification and formulation processes.
Opportunities
Expansion of human vaccine portfolio into emerging infectious diseases and leveraging One Health synergies to grow both animal and human vaccine markets globally.
Risk Factors
Regulatory and pricing pressures, dependence on government procurement, and intense competition from multinational vaccine manufacturers.
Competitive Landscape
Competes with Bharat Biotech, Serum Institute of India, Sanofi, Merck Animal Health, and Zoetis; differentiates through large‑scale veterinary vaccine capacity, first‑to‑market Indian tissue‑culture rabies vaccine, and a diversified cross‑species product mix.